Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Vaccines

  Free Subscription


Articles published in PLoS Biol

Retrieve available abstracts of 10 articles:
HTML format



Single Articles


    September 2022
  1. DAY T, Kennedy DA, Read AF, Gandon S, et al
    Pathogen evolution during vaccination campaigns.
    PLoS Biol. 2022;20:e3001804.
    PubMed     Abstract available


  2. KOEKEN VACM, Qi C, Mourits VP, de Bree LCJ, et al
    Plasma metabolome predicts trained immunity responses after antituberculosis BCG vaccination.
    PLoS Biol. 2022;20:e3001765.
    PubMed     Abstract available


    May 2022
  3. ZHU DY, Gorman MJ, Yuan D, Yu J, et al
    Defining the determinants of protection against SARS-CoV-2 infection and viral control in a dose-down Ad26.CoV2.S vaccine study in nonhuman primates.
    PLoS Biol. 2022;20:e3001609.
    PubMed     Abstract available


  4. LU-CULLIGAN A, Tabachnikova A, Perez-Then E, Tokuyama M, et al
    No evidence of fetal defects or anti-syncytin-1 antibody induction following COVID-19 mRNA vaccination.
    PLoS Biol. 2022;20:e3001506.
    PubMed     Abstract available


  5. SYENINA A, Gan ES, Toh JZN, de Alwis R, et al
    Adverse effects following anti-COVID-19 vaccination with mRNA-based BNT162b2 are alleviated by altering the route of administration and correlate with baseline enrichment of T and NK cell genes.
    PLoS Biol. 2022;20:e3001643.
    PubMed     Abstract available


    April 2022
  6. NUISMER SL
    One step closer to a transmissible vaccine for rabies virus.
    PLoS Biol. 2022;20:e3001607.
    PubMed     Abstract available


  7. GRIFFITHS ME, Broos A, Bergner LM, Meza DK, et al
    Longitudinal deep sequencing informs vector selection and future deployment strategies for transmissible vaccines.
    PLoS Biol. 2022;20:e3001580.
    PubMed     Abstract available


    December 2021
  8. AMANAT F, Strohmeier S, Meade P, Dambrauskas N, et al
    Vaccination with SARS-CoV-2 variants of concern protects mice from challenge with wild-type virus.
    PLoS Biol. 2021;19:e3001384.
    PubMed     Abstract available


    November 2021
  9. KESSIE DK, Rudel T
    Advanced human mucosal tissue models are needed to improve preclinical testing of vaccines.
    PLoS Biol. 2021;19:e3001462.
    PubMed     Abstract available


  10. MURUATO A, Vu MN, Johnson BA, Davis-Gardner ME, et al
    Mouse-adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge.
    PLoS Biol. 2021;19:e3001284.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: